Tenecteplase (Recombinant Human TNK Tissue-type Plasminogen Activator for Injection)

Strength: 1.0×107IU /16mg /Vial
Dosage Form: White or off white freeze-dried powder injection.



Dosage and Administration: This product shall be prescribed by physician with experience of thrombolytic therapy. Treatment of this product shall be started early after clinical symptoms of acute myocardial infarction. The product is used for thrombolytic therapy of STEMI. Single administration is 16mg. Dissolve 16 mg rhTNK-tPA(1vial) with 3ml sterile water for injection, The intravenous bolus injection shall be given and finished within 5~10s.

Therapeutic Indication:It is indicated for thrombolytic therapy for acute myocardial infarction occurring within 6 hours.

Precautions when using:

Copyright © 2019 凯时手机版集团有限公司. All rights reserved. ICP证0301